Value Hunters: Look To Genmab ADR (GMAB)
AllianceBernstein LP recently announced the acquisition of new stake in Genmab ADR (NASDAQ:GMAB). The institutional investor has increased its shareholding in the Healthcare company by 16.22% to 9.52 million shares with purchase of 1.33 million shares. This fresh investment now brings its stake to 1.44% valued currently at $300.78 million. In addition, Capital Research & […]
